Phibro Animal Health Corporation

PAHC · NasdaqGM · Stock · Healthcare
$37.93
+3.04% today
Delayed price,

What Phibro Animal Health does

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Key facts

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Market cap
$1.54B
P/E (ttm)
15.6
Forward P/E
9.9
Dividend yield
1.30%
Beta
0.42
Profit margin
6.6%
Employees
2,605
Headquarters
Teaneck, NJ, United States
Exchange
NasdaqGM

Performance

1 Month
+9.8%
3 Months
+13.9%
6 Months
-33.5%
1 Year
-4.5%
5 Years
+93.6%
$28.2552-week range$60.08
Biggest setback — last 12 months
-46.8%
6 Apr 2026 → 25 May 2026
Fell from $57.89 to $30.79 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+55.4%
15 Dec 2025 → 6 Apr 2026
Ran from $37.25 to $57.89 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$32.25 (-12.4%)$36.81$42.01 (+14.1%)
3 Months$29.28 (-20.5%)$36.81$46.28 (+25.7%)
6 Months$26.63 (-27.7%)$36.81$50.88 (+38.2%)
12 Months$23.29 (-36.7%)$36.81$58.19 (+58.1%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 45.8%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.